VanEck Associates
NUVA

VanEck Associates’s NuVasive, Inc. NUVA Stock Holding History

VanEck Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,929
Closed -$122K – 1427
2023
Q2 		$122K Hold
2,929
– – ﹤0.01% 1217
2023
Q1 		$121K Sell
2,929
-82
-3% -$3.51K ﹤0.01% 1225
2022
Q4 		$124K Buy
+3,011
New +$122K ﹤0.01% 1215

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VanEck Associates's NUVA Position: Q3 2023 in Review

VanEck Associates sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 2,929 shares — an estimated $122K sold.

VanEck Associates first reported a position in NUVA in Q4 2022 and held it in 3 quarters. The position peaked at $124K in Q4 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • VanEck Associates reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • VanEck Associates sold 2,929 NuVasive, Inc. shares in Q3 2023, an estimated $122K.
  • VanEck Associates first reported a position in NuVasive, Inc. in Q4 2022 and held it in 3 quarters.
  • VanEck Associates's NuVasive, Inc. position peaked at $124K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on VanEck Associates's 13F filing for Q3 2023, filed 8 Nov 2023.